Jump to content

Xofigo (Radium-223) treatment: Time to thank those who supported us


Recommended Posts

Our campaign to gain approval of Xofigo (Radium-223) treatment for prostate cancer in bones has been a success. The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended subsidised access to men who need it. The decision only awaits Cabinet approval.

Time to thank those who helped.

If you contacted your local member, or the Honourable the Minister, you may wish to thank them for their support.

Below is my letter to my local member:


Hon. Jane Prentice, MP
Assistant Minister for Social Services and Disability Services

Dear Assistant Minister
In March this year I asked for your support in getting the approval rules changed so a new type of prostate cancer treatment (Xofigo) could be made available to Australian men.

You took my concerns to the Hon the Minister for Health.

I am pleased to inform you that the minister acted, the rules were changed, and yesterday the Pharmaceutical Benefits Advisory Committee (PBAC) announced that it recommended that Xofigo (Radium-223) be approved for supply under the PBS.

This decision will improve the lives of thousands of men over the next few years. On behalf of these men and their families, I thank you for your help.


Jim Marshall
Australian Advanced Prostate Cancer Support Group
4 Balmore Street
Indooroopilly Qld 4068

Link to comment
Share on other sites

Well done Jim.  Your work in lobbying the big boys has paid off.  Thankyou for giving up your time.  Your persistence has paid off.  A great effort.  While there are many in need of this treatment now there are many of us who may this treatment in the future.  Having more treatment options in the future is very heartening for our families, friends and loved ones.  Furthermore it keeps the black dog in his kennel.  Thank you Jim for all your hard work



Link to comment
Share on other sites

  • Admin locked this topic


This topic is now archived and is closed to further replies.

This topic is now closed to further replies.
  • Create New...